These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 16503507)

  • 1. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in adults.
    ASBMT Executive Committee
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):368-9. PubMed ID: 16503507
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of acute lymphoblastic leukemia in children.
    ASBMT Executive Committee
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):370-1. PubMed ID: 16503508
    [No Abstract]   [Full Text] [Related]  

  • 3. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L; Labopin M; Gratwohl A; Gluckman E; Frassoni F; Beelen DW; Willemze R; Montserrat E; Blaise D; Atienza AI; Sierra J; Santos M; Gorin NC; Rocha V;
    Haematologica; 2008 Jun; 93(6):834-41. PubMed ID: 18469352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.
    Hahn T; Wall D; Camitta B; Davies S; Dillon H; Gaynon P; Larson RA; Parsons S; Seidenfeld J; Weisdorf D; McCarthy PL
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):1-30. PubMed ID: 16399566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a meta-analysis.
    Bartolozzi B; Bosi A; Orsi C
    Cancer; 2007 Jan; 109(2):343; author reply 344. PubMed ID: 17154182
    [No Abstract]   [Full Text] [Related]  

  • 6. Unrelated donor allogeneic transplantation for adult acute lymphoblastic leukemia: a review.
    Bachanova V; Weisdorf D
    Bone Marrow Transplant; 2008 Mar; 41(5):455-64. PubMed ID: 17968329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic cell transplantation is not recommended for all adults with standard-risk acute lymphoblastic leukemia in first complete remission.
    Larson RA
    Biol Blood Marrow Transplant; 2009 Jan; 15(1 Suppl):11-6. PubMed ID: 19147070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imatinib interim therapy between chemotherapeutic cycles and in vivo purging prior to autologous stem cell transplantation, followed by maintenance therapy is a feasible treatment strategy in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Shin HJ; Chung JS; Cho GJ
    Bone Marrow Transplant; 2005 Nov; 36(10):917-8. PubMed ID: 16113662
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in adults.
    Forman SJ
    Hematol Oncol Clin North Am; 2009 Oct; 23(5):1011-31, vi. PubMed ID: 19825450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hematopoietic stem cell transplantation should be performed in all patients with adult acute lymphoblastic leukemia in first complete remission].
    Ota S
    Rinsho Ketsueki; 2012 Jun; 53(6):594-603. PubMed ID: 22790634
    [No Abstract]   [Full Text] [Related]  

  • 11. Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: still not out of fashion.
    Doubek M; Folber F; Koristek Z; Brychtova Y; Krejci M; Tomiska M; Navratil M; Mikulasova P; Mayer J
    Ann Hematol; 2009 Sep; 88(9):881-7. PubMed ID: 19172272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the treatment of pediatric acute lymphoblastic leukemia: update of the 2005 evidence-based review. ASBMT Position Statement.
    Oliansky DM; Camitta B; Gaynon P; Nieder ML; Parsons SK; Pulsipher MA; Dillon H; Ratko TA; Wall D; McCarthy PL; Hahn T
    Biol Blood Marrow Transplant; 2012 Jul; 18(7):979-81. PubMed ID: 22490784
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of acute leukemia with allogeneic stem cell transplantation].
    Seiwerth RS; Mrsić M; Nemet D; Bogdanić V; Mikulić M; Sertić D; Grković L; Cecuk E; Bojanić I; Batinić D; Labar B
    Acta Med Croatica; 2009 Jun; 63(3):205-8. PubMed ID: 19827346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic cell transplantation in children with relapsed acute lymphoblastic leukemia isolated to the central nervous system.
    Harker-Murray PD; Thomas AJ; Wagner JE; Weisdorf D; Luo X; DeFor TE; Verneris MR; Dusenbery KE; MacMillan ML; Tolar J; Baker KS; Orchard PJ
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):685-92. PubMed ID: 18489994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia].
    Fløisand Y; Brinch L; Dybedal I; Gedde-Dahl T; Heldal D; Holme PA; Egeland T; Tjønnfjord GE
    Tidsskr Nor Laegeforen; 2008 Nov; 128(22):2563-6. PubMed ID: 19023351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retardation of platelet recovery after autologous stem cell transplantation in a patient with acute lymphoblastic leukemia: possible role of decreased thrombopoietin production by bone marrow stromal cells].
    Sakamaki S; Hirayama Y; Nagaoka Y; Kuroda H; Terui K; Kogawa K; Kato J; Niitsu Y
    Rinsho Ketsueki; 2000 Nov; 41(11):1178-82. PubMed ID: 11193436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia: a metaanalysis.
    Yanada M; Matsuo K; Suzuki T; Naoe T
    Cancer; 2006 Jun; 106(12):2657-63. PubMed ID: 16703597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the treatment of adults with acute lymphoblastic leukemia.
    Larson S; Stock W
    Curr Opin Hematol; 2008 Jul; 15(4):400-7. PubMed ID: 18536580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.